SFDA lot release policy
Policy Guidance for Lot Release of Biological Products
Current edition
Version 1.1 of September 1, 2010
Current edition
Version 1.1 of September 1, 2010
About this standard
The SFDA lot release testing program for biological products before sale in Saudi Arabia, before and after approval.
Recognition by market
Whether the market recognizes, harmonizes or adopts this standard, and which edition it accepts
No market listing is published yet.
Testing requirements that cite it
Open the market page and its pathway pages for the full requirement, protocol and report content
Saudi Arabia
- Lot release of vaccines, blood products and other biological products by SFDALot release and sample testing · Sample testing
Related standards: MHRA Responsible Person (import) guidance, EudraLex Volume 4 Annex 16, HC Lot Release Program guidance, TGA vaccine batch release, MFDS imported drug management regulation, MFDS national lot release regulation, RDC 669/2022, RDC 670/2022, RDC 900/2024, RDC 944/2024, Taiwan biological product lot release regulations. See all standards.